GU CANCERS
-
Recent Advances in Tivozanib plus Nivolumab Combinatorial Strategies in Renal Cell Carcinoma
Robert J Motzer, MD 1, Toni K Choueiri, MD 2, Laurence Albiges, MD, PhD 3,Robert A. Figlin, MD, FACP4 Memorial…
Read More » -
Keytruda plus Lenvima Combo Received FDA Approval for Advanced Kidney Cancer
August 20, 2021 Frontline Keytruda plus Lenvima for advanced renal cell carcinoma is an effective treatment with life-prolonging benefits, although…
Read More » -
Combo of cabozantinib plus atezolizumab active across kidney cancer subtypes
September 9, 2021 By Gregor Kreth Recent findings based on the phase 1b COSMIC-021 trial in Journal of Clinical Oncology…
Read More » -
US FDA Approves Belzutifan for Tumors Associated With Certain Types of Von Hippel-Lindau Disease
By Gregor Kreth, Guest Writer August 16, 2021 FDA approves Merck’s Welireg for the treatment of adult patients with von…
Read More » -
ASCO21 Meeting Summary – Kidney Cancer
Practice Changing Results in RCC come from ASCO 2021 Ochsner Precision Cancer Therapies Program and Ochsner Cancer Institute, Benson Cancer…
Read More » -
Editor’s Memo
Robert A. Figlin MD Novel Drug Combinations Gain Traction Across Therapeutic Landscape More than a year since the COVID-19 crisis…
Read More » -
Study Discovers Link Between Electronic Cigarette Use and Bladder Cancer
March 29, 2021 By Christopher Brown Substances linked to bladder cancer found in the urine of e-cigarette users Recently published…
Read More » -
Updated NCCN Guideline Recommends Tivozanib Regimen in Clear Cell Renal Cell Carcinoma
Christoph Baker Mar 29 | 2021 National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include FOTIVDA® (tivozanib)…
Read More » -
Guidelines for Kidney Cancer Treatment
A list of global guidelines for kidney cancer are provided in this section. These guidelines provide evidence-based recommendations to serve as a guide…
Read More »
